Clinical implications of FDG PETCT in cancer of unknown primaries
Cancer of unknown primary (CUP) has an incidence of 3.3% in the UK but this is falling, largely due to improvement in diagnostics, enabling underlying pathology to be identified and treated, therefore improving survival outcomes. F-18 FDG PETCT is increasingly being used to investigate for malignancy in patients in whom initial tests have proven inconclusive […]
Emily Vaughan, Shaunak Navalkissoor
Royal Free London NHS Foundation Trust